SUNPHARMA.BOSUNPHARMA.BO
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$149.68B
↑ 57% above average
Average (9y)
$95.24B
Historical baseline
Range
High:$149.68B
Low:$55.68B
CAGR
+6.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $149.68B | +16.2% |
| 2024 | $128.76B | +10.5% |
| 2023 | $116.51B | +14.8% |
| 2022 | $101.54B | +21.7% |
| 2021 | $83.45B | +21.7% |
| 2020 | $68.57B | +6.1% |
| 2019 | $64.60B | +16.0% |
| 2018 | $55.68B | -43.3% |
| 2017 | $98.13B | +14.8% |
| 2016 | $85.48B | - |